
BTK
BTK (Bruton's tyrosine kinase) inhibitors are compounds that specifically target and inhibit BTK, a crucial enzyme involved in B-cell receptor signaling and the regulation of angiogenesis. BTK plays a significant role in the proliferation and survival of cancer cells, particularly in hematological malignancies. By inhibiting BTK, these compounds can disrupt angiogenesis and tumor growth, making them valuable in cancer therapy. At CymitQuimica, we offer a range of high-quality BTK inhibitors to support your research in oncology, immunology, and angiogenesis.
Products of "BTK"
Sort by
Edralbrutinib
CAS:Edralbrutinib (TG-1701) is a potent BTK inhibitor with anticancer activity and is used in the treatment of tumors, immune system disorders, and blood andFormula:C26H21F2N5O3Purity:99.47%Color and Shape:SolidMolecular weight:489.47BTK IN-1
CAS:BTK IN-1 (SNS062 analog) (SNS062 analog) is an effective BTK inhibitor (IC50: <100 nM).Formula:C19H21ClN6OPurity:97.38%Color and Shape:SolidMolecular weight:384.86Ref: TM-TQ0230
1mg38.00€2mg49.00€5mg80.00€10mg111.00€25mg180.00€50mg311.00€100mg439.00€1mL*10mM (DMSO)88.00€CGI-1746
CAS:CGI1746 is a potent and highly selective small-molecule Btk inhibitor with IC50 of 1.9 nM.Formula:C34H37N5O4Purity:97.69% - 97.88%Color and Shape:SolidMolecular weight:579.69Tolebrutinib
CAS:Tolebrutinib is an oral, selective BTK inhibitor, effective for MS research, with brain penetration and IC50s of 0.4/0.7 nM in cells.Formula:C26H25N5O3Purity:98.40% - 98.82%Color and Shape:SolidMolecular weight:455.51Ref: TM-T9125
2mg43.00€5mg74.00€10mg111.00€25mg187.00€50mg279.00€100mg459.00€200mg657.00€1mL*10mM (DMSO)85.00€evobrutinib
CAS:Evobrutinib(M2951) , also known as M-2951 and MSC-2364447C, is a highly selective inhibitor of the Bruton's tyrosine kinase (BTK), which is important in theFormula:C25H27N5O2Purity:99.01% - 99.58%Color and Shape:SolidMolecular weight:429.51Ref: TM-T4387
1mg42.00€5mg88.00€10mg127.00€25mg227.00€50mg329.00€100mg472.00€500mg1,017.00€1mL*10mM (DMSO)87.00€BMS-986142
CAS:BMS-986142 is a potent and highly selective reversible BTK inhibitor (IC50: 0.5 nM).Formula:C32H30F2N4O4Purity:98.7% - 99.76%Color and Shape:SolidMolecular weight:572.6Ref: TM-T5138
1mg140.00€5mg378.00€10mg600.00€25mg939.00€50mg1,264.00€100mg1,691.00€200mg2,308.00€500mg3,410.00€1mL*10mM (DMSO)487.00€BTK-IN-40
CAS:BTK-IN-40 (compound 375) is an inhibitor of BTK.Formula:C20H25N7O2Color and Shape:SolidMolecular weight:395.46Remibrutinib
CAS:Remibrutinib inhibits BTK activity with an IC50 value of 0.023 μM in blood.Formula:C27H27F2N5O3Purity:99.5% - 99.81%Color and Shape:SolidMolecular weight:507.53Ref: TM-T16730
1mg97.00€5mg221.00€10mg359.00€25mg603.00€50mg753.00€100mg1,159.00€200mg1,568.00€1mL*10mM (DMSO)248.00€CNX-774
CAS:CNX-774 is a highly specific, irreversible, and orally active BTK inhibitor (IC50<1 nM).Formula:C26H22FN7O3Purity:97.35% - 99.11%Color and Shape:SolidMolecular weight:499.5Ref: TM-T2302
1mg40.00€2mg52.00€5mg88.00€10mg126.00€25mg235.00€50mg389.00€100mg567.00€500mg1,225.00€1mL*10mM (DMSO)93.00€Rilzabrutinib
CAS:Rilzabrutinib (PRN1008) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK)(IC50 of 1.3 nM).Formula:C36H40FN9O3Purity:97.87% - 99.76%Color and Shape:SolidMolecular weight:665.76Ref: TM-T12542
1mg99.00€5mg235.00€10mg376.00€25mg655.00€50mg944.00€100mg1,320.00€500mg2,642.00€1mL*10mM (DMSO)344.00€